Vladimir Kalinichenko, MD, PhD Takes up Post as Director, Strengthens Focus on Bench-to-Bedside ResearchContinue reading
Author Archive: AZBio
UArizona COVID-19 Treatment Takes Next Step Toward Public Impact via License to Pharmaceutical Company
A compound developed by researchers at the R. Ken Coit College of Pharmacy moves one step closer to commercialization with licensing agreement.
A study conducted by researchers at the University of Arizona Health Sciences and the University of Illinois found that viral loads of the SARS-CoV-2 virus can be reduced by small molecule PLpro inhibitors.Continue reading
Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
INDIANAPOLIS, March 1, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month. Lilly is taking these actions to make it easier to access Lilly insulin and help Americans who may have difficulty navigating a complex healthcare system that may keep them from getting affordable insulin. (Download PDF)
Dignity Health St. Joseph’s Hospital and Medical Center launches new initiative to address health disparities of African Americans with chronic kidney disease
PHOENIX, Feb. 27, 2023 (GLOBE NEWSWIRE) — Dignity Health St. Joseph’s Hospital and Medical Center has launched a new initiative to address race-based algorithms in early diagnosis of chronic kidney disease. The launch of the program marks a significant step towards removing barriers that have long plagued racial and ethnic minorities, particularly African Americans. The initiative is being led by CommonSpirit Health, of which St. Joseph’s is a member.Continue reading
HonorHealth Research Institute implants first state-of-the-art modified pacemaker system in an Arizona patient
Two-device system is designed to detect and treat ventricular fibrillation, providing heart patients with a permanent, potentially life-saving way to keep their heart from beating out of control.Continue reading
AZBio and RESI Partner on Free Audience Pass for AZBio Members at RESI Digital in March 2023
Arizona Bioindustry Association (AZBio) Partners with Digital RESI March 14-16th Offering “Seeing is Believing”
FREE Audience Access Pass to Members
Continue reading
How You Can Impact Arizona’s Innovation Future
Grass roots advocacy is when people engage in the legislative process by sharing their views with their elected leaders. It can take the form of writing or signing on to letters, testifying at hearings, attending town halls, visiting an elected leader at their office; or, here in Arizona, sharing their position on bills at the Legislature using the Request to Speak System. Continue reading
Funding for the Arizona Health Innovation Trust Fund Passes in Senate Appropriations
The Arizona Health Innovation Trust Fund (AHIT) was established in 2022 to develop workforce programs; support small health innovation businesses; and provide other financial support that will drive growth in Arizona’s life science sector. On February 23, 2023, SB1084 was amended to appropriate $50 million in funding for AHIT in Arizona’s FY24 budget and declares that the Legislature intends that the Fund steadily grows to maintain a permanent endowment balance of at least $200 million. The amended bill received a Do Pass as Amended recommendation. SB1084 now moves to consideration by the Senate Rules Committee.Continue reading
Updates to Arizona’s R and D Tax Credits Under Consideration at Arizona Legislature
On February 23,2023, the Arizona Senate Appropriations gave a Do Pass Recommendation to SB1562 which updates and expands Arizona’s R&D Tax Credit program.Continue reading